Effect of removing Kupffer cells on nanoparticle tumor delivery

Anthony J. Tavares, Wilson Poon, Yi Nan Zhang, Qin Dai, Rickvinder Besla, Ding Ding, Ben Ouyang, Angela Li, Juan Chen, Gang Zheng, Clinton Robbins, Warren C.W. Chan, Catherine J. Murphy

Research output: Contribution to journalArticle

Abstract

A recent metaanalysis shows that 0.7% of nanoparticles are delivered to solid tumors. This low delivery efficiency has major implications in the translation of cancer nanomedicines, as most of the nanomedicines are sequestered by nontumor cells. To improve the delivery efficiency, there is a need to investigate the quantitative contribution of each organ in blocking the transport of nanoparticles to solid tumors. Here, we hypothesize that the removal of the liver macrophages, cells that have been reported to take up the largest amount of circulating nanoparticles, would lead to a significant increase in the nanoparticle delivery efficiency to solid tumors. We were surprised to discover that the maximum achievable delivery efficiency was only 2%. In our analysis, there was a clear correlation between particle design, chemical composition, macrophage depletion, tumor pathophysiology, and tumor delivery efficiency. In many cases, we observed an 18-150 times greater delivery efficiency, but we were not able to achieve a delivery efficiency higher than 2%. The results suggest the need to look deeper at other organs such as the spleen, lymph nodes, and tumor in mediating the delivery process. Systematically mapping the contribution of each organ quantitatively will allow us to pinpoint the cause of the low tumor delivery efficiency. This, in effect, enables the generation of a rational strategy to improve the delivery efficiency of nanoparticles to solid tumors either through the engineering of multifunctional nanosystems or through manipulation of biological barriers.

Original languageEnglish (US)
Pages (from-to)E10871-E10880
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number51
DOIs
StatePublished - Dec 19 2017

Fingerprint

Kupffer Cells
Nanoparticles
Neoplasms
Nanomedicine
Macrophages
Cohort Effect
Spleen
Lymph Nodes
Liver

Keywords

  • Cancer
  • Liver
  • Macrophage
  • Nanoparticle
  • Tumor delivery

ASJC Scopus subject areas

  • General

Cite this

Effect of removing Kupffer cells on nanoparticle tumor delivery. / Tavares, Anthony J.; Poon, Wilson; Zhang, Yi Nan; Dai, Qin; Besla, Rickvinder; Ding, Ding; Ouyang, Ben; Li, Angela; Chen, Juan; Zheng, Gang; Robbins, Clinton; Chan, Warren C.W.; Murphy, Catherine J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 51, 19.12.2017, p. E10871-E10880.

Research output: Contribution to journalArticle

Tavares, AJ, Poon, W, Zhang, YN, Dai, Q, Besla, R, Ding, D, Ouyang, B, Li, A, Chen, J, Zheng, G, Robbins, C, Chan, WCW & Murphy, CJ 2017, 'Effect of removing Kupffer cells on nanoparticle tumor delivery', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 51, pp. E10871-E10880. https://doi.org/10.1073/pnas.1713390114
Tavares, Anthony J. ; Poon, Wilson ; Zhang, Yi Nan ; Dai, Qin ; Besla, Rickvinder ; Ding, Ding ; Ouyang, Ben ; Li, Angela ; Chen, Juan ; Zheng, Gang ; Robbins, Clinton ; Chan, Warren C.W. ; Murphy, Catherine J. / Effect of removing Kupffer cells on nanoparticle tumor delivery. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 51. pp. E10871-E10880.
@article{3060ee0bf3e04a8f99da2e3cc470f8af,
title = "Effect of removing Kupffer cells on nanoparticle tumor delivery",
abstract = "A recent metaanalysis shows that 0.7{\%} of nanoparticles are delivered to solid tumors. This low delivery efficiency has major implications in the translation of cancer nanomedicines, as most of the nanomedicines are sequestered by nontumor cells. To improve the delivery efficiency, there is a need to investigate the quantitative contribution of each organ in blocking the transport of nanoparticles to solid tumors. Here, we hypothesize that the removal of the liver macrophages, cells that have been reported to take up the largest amount of circulating nanoparticles, would lead to a significant increase in the nanoparticle delivery efficiency to solid tumors. We were surprised to discover that the maximum achievable delivery efficiency was only 2{\%}. In our analysis, there was a clear correlation between particle design, chemical composition, macrophage depletion, tumor pathophysiology, and tumor delivery efficiency. In many cases, we observed an 18-150 times greater delivery efficiency, but we were not able to achieve a delivery efficiency higher than 2{\%}. The results suggest the need to look deeper at other organs such as the spleen, lymph nodes, and tumor in mediating the delivery process. Systematically mapping the contribution of each organ quantitatively will allow us to pinpoint the cause of the low tumor delivery efficiency. This, in effect, enables the generation of a rational strategy to improve the delivery efficiency of nanoparticles to solid tumors either through the engineering of multifunctional nanosystems or through manipulation of biological barriers.",
keywords = "Cancer, Liver, Macrophage, Nanoparticle, Tumor delivery",
author = "Tavares, {Anthony J.} and Wilson Poon and Zhang, {Yi Nan} and Qin Dai and Rickvinder Besla and Ding Ding and Ben Ouyang and Angela Li and Juan Chen and Gang Zheng and Clinton Robbins and Chan, {Warren C.W.} and Murphy, {Catherine J.}",
year = "2017",
month = "12",
day = "19",
doi = "10.1073/pnas.1713390114",
language = "English (US)",
volume = "114",
pages = "E10871--E10880",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "51",

}

TY - JOUR

T1 - Effect of removing Kupffer cells on nanoparticle tumor delivery

AU - Tavares, Anthony J.

AU - Poon, Wilson

AU - Zhang, Yi Nan

AU - Dai, Qin

AU - Besla, Rickvinder

AU - Ding, Ding

AU - Ouyang, Ben

AU - Li, Angela

AU - Chen, Juan

AU - Zheng, Gang

AU - Robbins, Clinton

AU - Chan, Warren C.W.

AU - Murphy, Catherine J.

PY - 2017/12/19

Y1 - 2017/12/19

N2 - A recent metaanalysis shows that 0.7% of nanoparticles are delivered to solid tumors. This low delivery efficiency has major implications in the translation of cancer nanomedicines, as most of the nanomedicines are sequestered by nontumor cells. To improve the delivery efficiency, there is a need to investigate the quantitative contribution of each organ in blocking the transport of nanoparticles to solid tumors. Here, we hypothesize that the removal of the liver macrophages, cells that have been reported to take up the largest amount of circulating nanoparticles, would lead to a significant increase in the nanoparticle delivery efficiency to solid tumors. We were surprised to discover that the maximum achievable delivery efficiency was only 2%. In our analysis, there was a clear correlation between particle design, chemical composition, macrophage depletion, tumor pathophysiology, and tumor delivery efficiency. In many cases, we observed an 18-150 times greater delivery efficiency, but we were not able to achieve a delivery efficiency higher than 2%. The results suggest the need to look deeper at other organs such as the spleen, lymph nodes, and tumor in mediating the delivery process. Systematically mapping the contribution of each organ quantitatively will allow us to pinpoint the cause of the low tumor delivery efficiency. This, in effect, enables the generation of a rational strategy to improve the delivery efficiency of nanoparticles to solid tumors either through the engineering of multifunctional nanosystems or through manipulation of biological barriers.

AB - A recent metaanalysis shows that 0.7% of nanoparticles are delivered to solid tumors. This low delivery efficiency has major implications in the translation of cancer nanomedicines, as most of the nanomedicines are sequestered by nontumor cells. To improve the delivery efficiency, there is a need to investigate the quantitative contribution of each organ in blocking the transport of nanoparticles to solid tumors. Here, we hypothesize that the removal of the liver macrophages, cells that have been reported to take up the largest amount of circulating nanoparticles, would lead to a significant increase in the nanoparticle delivery efficiency to solid tumors. We were surprised to discover that the maximum achievable delivery efficiency was only 2%. In our analysis, there was a clear correlation between particle design, chemical composition, macrophage depletion, tumor pathophysiology, and tumor delivery efficiency. In many cases, we observed an 18-150 times greater delivery efficiency, but we were not able to achieve a delivery efficiency higher than 2%. The results suggest the need to look deeper at other organs such as the spleen, lymph nodes, and tumor in mediating the delivery process. Systematically mapping the contribution of each organ quantitatively will allow us to pinpoint the cause of the low tumor delivery efficiency. This, in effect, enables the generation of a rational strategy to improve the delivery efficiency of nanoparticles to solid tumors either through the engineering of multifunctional nanosystems or through manipulation of biological barriers.

KW - Cancer

KW - Liver

KW - Macrophage

KW - Nanoparticle

KW - Tumor delivery

UR - http://www.scopus.com/inward/record.url?scp=85038815395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038815395&partnerID=8YFLogxK

U2 - 10.1073/pnas.1713390114

DO - 10.1073/pnas.1713390114

M3 - Article

C2 - 29208719

AN - SCOPUS:85038815395

VL - 114

SP - E10871-E10880

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 51

ER -